MedAvail Holdings Inc
OTC:MDVLQ
MedAvail Holdings Inc
Cost of Revenue
MedAvail Holdings Inc
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
MedAvail Holdings Inc
OTC:MDVLQ
|
Cost of Revenue
-$22.2m
|
CAGR 3-Years
-237%
|
CAGR 5-Years
-152%
|
CAGR 10-Years
-36%
|
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
Cost of Revenue
-$117.8B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-8%
|
|
M
|
Mangoceuticals Inc
NASDAQ:MGRX
|
Cost of Revenue
-$300k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is MedAvail Holdings Inc's Cost of Revenue?
Cost of Revenue
-22.2m
USD
Based on the financial report for Jun 30, 2023, MedAvail Holdings Inc's Cost of Revenue amounts to -22.2m USD.
What is MedAvail Holdings Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-36%
Over the last year, the Cost of Revenue growth was -62%. The average annual Cost of Revenue growth rates for MedAvail Holdings Inc have been -237% over the past three years , -152% over the past five years , and -36% over the past ten years .